The pharmacology of McN-A-343
- 1 August 2012
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 135 (2) , 216-245
Abstract
No abstract availableKeywords
This publication has 330 references indexed in Scilit:
- Investigating the interaction of McN-A-343 with the M2 muscarinic receptor using its nitrogen mustard derivativeBiochemical Pharmacology, 2010
- The spinal muscarinic receptor subtypes contribute to the morphine-induced antinociceptive effects in thermal stimulation in miceNeuroscience Letters, 2004
- The design and pharmacology of novel selective muscarinic agonists and antagonistsLife Sciences, 1995
- Pre- and postjunctional muscarinic receptor subtypes in the vas deferens of ratGeneral Pharmacology: The Vascular System, 1994
- New functionally selective muscarinic agonistsLife Sciences, 1993
- Pharmacology characterization of guanine nucleotide exchange reactions in membranes from Cho cells stably transfected with human muscarinic receptors m1–m4Life Sciences, 1993
- Involvement of the muscarinic receptors in the postsynaptic potentiation of neurogenic twitch contraction in the mouse vas deferensLife Sciences, 1992
- Effects of muscarinic receptor agonists and antagonists on rat brain serotonergic activityJournal of Neural Transmission, 1992
- McN-A-343, a specific agonist of M1-muscarinic receptors, exerts antinicotinic and antimuscarinic effects in the rat adrenal medullaLife Sciences, 1986
- A comparison of the antimuscarinic effects of pirenzepine and N-methylatropine on ganglionic and vascular muscarinic receptors in the ratLife Sciences, 1984